BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 15535833)

  • 1. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
    Trysberg E; Blennow K; Zachrisson O; Tarkowski A
    Arthritis Res Ther; 2004; 6(6):R551-6. PubMed ID: 15535833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.
    Trysberg E; Nylen K; Rosengren LE; Tarkowski A
    Arthritis Rheum; 2003 Oct; 48(10):2881-7. PubMed ID: 14558094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
    Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
    Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
    Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus.
    Isshi K; Hirohata S
    Arthritis Rheum; 1998 Oct; 41(10):1819-27. PubMed ID: 9778223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis.
    Lee KY; Kim EH; Yang WS; Ryu H; Cho SN; Lee BI; Heo JH
    J Neurol Sci; 2004 May; 220(1-2):73-8. PubMed ID: 15140609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Chang YH; Lin IL; Tsay GJ; Yang SC; Yang TP; Ho KT; Hsu TC; Shiau MY
    Clin Biochem; 2008 Aug; 41(12):955-9. PubMed ID: 18471998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement.
    Trysberg E; Carlsten H; Tarkowski A
    Lupus; 2000; 9(7):498-503. PubMed ID: 11035414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity.
    Hirohata S; Hirose S; Miyamoto T
    Arch Intern Med; 1985 Oct; 145(10):1843-6. PubMed ID: 3899036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased intrathecal immunoglobulin synthesis of both kappa and lambda types in patients with systemic lupus erythematosus and central nervous system involvement.
    Hirohata S; Miyamoto T
    J Rheumatol; 1986 Aug; 13(4):715-21. PubMed ID: 3095548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin.
    Katsumata Y; Harigai M; Kawaguchi Y; Fukasawa C; Soejima M; Takagi K; Tanaka M; Ichida H; Tochimoto A; Kanno T; Nishimura K; Kamatani N; Hara M
    J Rheumatol; 2007 Oct; 34(10):2010-7. PubMed ID: 17896804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases.
    Kang EH; Shen GQ; Morris R; Metzger A; Lee EY; Lee YJ; Lee EB; Song YW
    Lupus; 2008 Jan; 17(1):21-5. PubMed ID: 18089679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions.
    Kelly MC; Denburg JA
    J Rheumatol; 1987 Aug; 14(4):740-4. PubMed ID: 3668979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of children with echovirus type 30 and mumps meningitis.
    Sulik A; Wojtkowska M; Oldak E
    Scand J Immunol; 2008 Sep; 68(3):323-7. PubMed ID: 18565120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis.
    Fainardi E; Castellazzi M; Tamborino C; Trentini A; Manfrinato MC; Baldi E; Tola MR; Dallocchio F; Granieri E; Bellini T
    Mult Scler; 2009 May; 15(5):547-54. PubMed ID: 19318509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
    Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ
    Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
    Fragoso-Loyo H; Richaud-Patin Y; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Llorente L; Sánchez-Guerrero J
    Arthritis Rheum; 2007 Apr; 56(4):1242-50. PubMed ID: 17393453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease.
    Kozora E; West SG; Kotzin BL; Julian L; Porter S; Bigler E
    Arthritis Rheum; 1998 Jan; 41(1):41-7. PubMed ID: 9433868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus.
    Sanders ME; Alexander EL; Koski CL; Frank MM; Joiner KA
    J Immunol; 1987 Apr; 138(7):2095-9. PubMed ID: 3559203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.